Concepedia

Michelle So

MS

13

Publications

3.9K

Citations

13

H-Index

2006

Active since

Affiliations

University of California, Davis(Current)

The University of Melbourne

Royal Children's Hospital

St Vincent's Hospital Melbourne

The Royal Melbourne Hospital

Michelle So is an author at University of California, Davis specializing in medicine, diabetes, and metabolic syndrome.

ORCID

Top concepts

Publications per year

2006–2023

13

Publications

13

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes

Michaela Waibel, John M. Wentworth, Michelle So et al. · New England Journal of Medicine · 2023 · 158 citations

Proinsulin C-peptide is an autoantigen in people with type 1 diabetes

Michelle So, Colleen M. Elso, Eleonora Tresoldi et al. · Proceedings of the National Academy of Sciences · 2018 · 63 citations · Full text

Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice

Hsin‐ya Yang, Fernando A. Fierro, Michelle So et al. · Stem Cells Translational Medicine · 2020 · 53 citations · Full text

Rows per page

1–5 of 13